A significant discovery in cancer investigation is arising with the use of nanobodies to re-engage dysfunctional p53. This essential malignant inhibitor protein is frequently disabled in many forms of tumors, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research